Homology Medicines (FIXX) PT Lowered to $3 at RBC Capital

November 11, 2022 6:16 AM EST
Get Alerts FIXX Hot Sheet
Price: $1.44 -4%

Rating Summary:
    8 Buy, 5 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 18 | Down: 24 | New: 19
Join SI Premium – FREE
RBC Capital analyst Luca Issi lowered the price target on Homology Medicines (NASDAQ: FIXX) to $3.00 (from $4.00) while maintaining a Sector Perform rating.

You May Also Be Interested In

Related Categories

Analyst PT Change